89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76,678,746 | -13.0% | 4,966,240 | +6.8% | 0.00% | 0.0% |
Q2 2023 | $88,120,968 | +363.0% | 4,650,183 | +272.1% | 0.00% | +100.0% |
Q1 2023 | $19,030,983 | +39.8% | 1,249,572 | +16.8% | 0.00% | – |
Q4 2022 | $13,615,766 | +158.4% | 1,069,581 | +17.5% | 0.00% | – |
Q3 2022 | $5,269,000 | +210.1% | 910,042 | +72.6% | 0.00% | – |
Q2 2022 | $1,699,000 | -51.1% | 527,365 | -42.8% | 0.00% | – |
Q1 2022 | $3,476,000 | -68.8% | 922,230 | +8.3% | 0.00% | – |
Q4 2021 | $11,133,000 | -22.4% | 851,741 | +16.3% | 0.00% | – |
Q3 2021 | $14,348,000 | +3.7% | 732,394 | -1.0% | 0.00% | – |
Q2 2021 | $13,832,000 | -16.7% | 739,603 | +5.4% | 0.00% | – |
Q1 2021 | $16,611,000 | +3.5% | 701,492 | +6.5% | 0.00% | -100.0% |
Q4 2020 | $16,056,000 | +43.6% | 658,833 | +51.2% | 0.00% | – |
Q3 2020 | $11,180,000 | +162.1% | 435,686 | +103.6% | 0.00% | – |
Q2 2020 | $4,265,000 | -22.4% | 213,977 | -1.7% | 0.00% | – |
Q1 2020 | $5,498,000 | +14.0% | 217,748 | +18.8% | 0.00% | – |
Q4 2019 | $4,822,000 | – | 183,322 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |